Stem Cell Umbilical Cord Blood (UCB) Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Stem Cell Umbilical Cord Blood (UCB) Market to 2027 - Global Analysis and Forecasts By Storage Option (Private UCB Banks and Public UCB Banks); Disease (Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia, Lymphoma, Metabolic/Storage Diseases and Other Diseases) and Geography

Report Code: TIPRE00005170 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Stem cells from umbilical cord blood is preserved as it has capabilities of regenerating into any type of body cells. In life threatening malignant and non-malignant diseases, hematopoietic stem cells transplantation (HSCT) can help in saving the life of person. In addition, the therapy is comparatively cost effective and has limited side effects. Umbilical stem cells are used for treating cancer, blood diseases like anemia and certain immune system disorders.

MARKET DYNAMICS
The stem cell umbilical cord blood (UCB) market is anticipated to grow in the forecast period owing to increasing occurrence of chronic diseases as well as rising support of government and private sector for research and development. In addition, the growing popularity for umbilical cord storage in developing countries is expected to create opportunities for market growth during the forecast period

MARKET SCOPE
The "Global Stem Cell Umbilical Cord Blood (UCB) Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of stem cell umbilical cord blood (UCB) market with detailed market segmentation by storage option, disease and geography. The global stem cell umbilical cord blood (UCB) market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading stem cell umbilical cord blood (UCB) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global stem cell umbilical cord blood (UCB) market is segmented on the basis of storage option, disease. Based on storage option, the market is bifurcated into private UCB banks and public UCB banks. On the basis of disease, the market is classified as bone marrow failure syndrome, immune deficiencies, leukemia, lymphoma, metabolic/storage diseases and other diseases.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global stem cell umbilical cord blood (UCB) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stem cell umbilical cord blood (UCB) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting stem cell umbilical cord blood (UCB) market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the stem cell umbilical cord blood (UCB) market in these regions.
MARKET PLAYERS
The reports cover key developments in the stem cell umbilical cord blood (UCB) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from stem cell umbilical cord blood (UCB) market are anticipated to lucrative growth opportunities in the future with the rising demand for stem cell umbilical cord blood (UCB) market in the global market. Below mentioned is the list of few companies engaged in the stem cell umbilical cord blood (UCB) market.

The report also includes the profiles of key stem cell umbilical cord blood (UCB) market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  •  CBR Systems, Inc.
  •  Cordlife Sciences India Pvt. Ltd.
  •  Cryo-Cell International, Inc.
  •  CryoSave
  •  Cryoviva India
  •  Global Cord Blood Corporation
  •  Lifecell
  •  Regrow Biosciences Pvt. Ltd.
  •  Smart Cells International Ltd.
  •  ViaCord
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Stem Cell Umbilical Cord Blood (UCB) Market - By Storage Option
1.3.2 Stem Cell Umbilical Cord Blood (UCB) Market - By Disease
1.3.3 Stem Cell Umbilical Cord Blood (UCB) Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET - GLOBAL MARKET ANALYSIS
6.1. STEM CELL UMBILICAL CORD BLOOD (UCB) - GLOBAL MARKET OVERVIEW
6.2. STEM CELL UMBILICAL CORD BLOOD (UCB) - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET - REVENUE AND FORECASTS TO 2027 - STORAGE OPTION
7.1. OVERVIEW
7.2. STORAGE OPTION MARKET FORECASTS AND ANALYSIS
7.3. PRIVATE UCB BANKS
7.3.1. Overview
7.3.2. Private UCB Banks Market Forecast and Analysis
7.4. PUBLIC UCB BANKS
7.4.1. Overview
7.4.2. Public UCB Banks Market Forecast and Analysis
8. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE
8.1. OVERVIEW
8.2. DISEASE MARKET FORECASTS AND ANALYSIS
8.3. BONE MARROW FAILURE SYNDROME
8.3.1. Overview
8.3.2. Bone Marrow Failure Syndrome Market Forecast and Analysis
8.4. IMMUNE DEFICIENCIES
8.4.1. Overview
8.4.2. Immune Deficiencies Market Forecast and Analysis
8.5. LEUKEMIA
8.5.1. Overview
8.5.2. Leukemia Market Forecast and Analysis
8.6. LYMPHOMA
8.6.1. Overview
8.6.2. Lymphoma Market Forecast and Analysis
8.7. METABOLIC/STORAGE DISEASES
8.7.1. Overview
8.7.2. Metabolic/Storage Diseases Market Forecast and Analysis
8.8. OTHER DISEASES
8.8.1. Overview
8.8.2. Other Diseases Market Forecast and Analysis

9. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Stem Cell Umbilical Cord Blood (UCB) Market Overview
9.1.2 North America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis
9.1.3 North America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Storage Option
9.1.4 North America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Disease
9.1.5 North America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Countries
9.1.5.1 United States Stem Cell Umbilical Cord Blood (UCB) Market
9.1.5.1.1 United States Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.1.5.1.2 United States Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.1.5.2 Canada Stem Cell Umbilical Cord Blood (UCB) Market
9.1.5.2.1 Canada Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.1.5.2.2 Canada Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.1.5.3 Mexico Stem Cell Umbilical Cord Blood (UCB) Market
9.1.5.3.1 Mexico Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.1.5.3.2 Mexico Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.2. EUROPE
9.2.1 Europe Stem Cell Umbilical Cord Blood (UCB) Market Overview
9.2.2 Europe Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis
9.2.3 Europe Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Storage Option
9.2.4 Europe Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Disease
9.2.5 Europe Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Stem Cell Umbilical Cord Blood (UCB) Market
9.2.5.1.1 Germany Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.2.5.1.2 Germany Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.2.5.2 France Stem Cell Umbilical Cord Blood (UCB) Market
9.2.5.2.1 France Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.2.5.2.2 France Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.2.5.3 Italy Stem Cell Umbilical Cord Blood (UCB) Market
9.2.5.3.1 Italy Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.2.5.3.2 Italy Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.2.5.4 Spain Stem Cell Umbilical Cord Blood (UCB) Market
9.2.5.4.1 Spain Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.2.5.4.2 Spain Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.2.5.5 United Kingdom Stem Cell Umbilical Cord Blood (UCB) Market
9.2.5.5.1 United Kingdom Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.2.5.5.2 United Kingdom Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Stem Cell Umbilical Cord Blood (UCB) Market Overview
9.3.2 Asia-Pacific Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis
9.3.3 Asia-Pacific Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Storage Option
9.3.4 Asia-Pacific Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Disease
9.3.5 Asia-Pacific Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Stem Cell Umbilical Cord Blood (UCB) Market
9.3.5.1.1 Australia Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.3.5.1.2 Australia Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.3.5.2 China Stem Cell Umbilical Cord Blood (UCB) Market
9.3.5.2.1 China Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.3.5.2.2 China Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.3.5.3 India Stem Cell Umbilical Cord Blood (UCB) Market
9.3.5.3.1 India Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.3.5.3.2 India Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.3.5.4 Japan Stem Cell Umbilical Cord Blood (UCB) Market
9.3.5.4.1 Japan Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.3.5.4.2 Japan Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.3.5.5 South Korea Stem Cell Umbilical Cord Blood (UCB) Market
9.3.5.5.1 South Korea Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.3.5.5.2 South Korea Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Stem Cell Umbilical Cord Blood (UCB) Market Overview
9.4.2 Middle East and Africa Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis
9.4.3 Middle East and Africa Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Storage Option
9.4.4 Middle East and Africa Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Disease
9.4.5 Middle East and Africa Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Stem Cell Umbilical Cord Blood (UCB) Market
9.4.5.1.1 South Africa Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.4.5.1.2 South Africa Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.4.5.2 Saudi Arabia Stem Cell Umbilical Cord Blood (UCB) Market
9.4.5.2.1 Saudi Arabia Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.4.5.2.2 Saudi Arabia Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.4.5.3 U.A.E Stem Cell Umbilical Cord Blood (UCB) Market
9.4.5.3.1 U.A.E Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.4.5.3.2 U.A.E Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Stem Cell Umbilical Cord Blood (UCB) Market Overview
9.5.2 South and Central America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis
9.5.3 South and Central America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Storage Option
9.5.4 South and Central America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Disease
9.5.5 South and Central America Stem Cell Umbilical Cord Blood (UCB) Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Stem Cell Umbilical Cord Blood (UCB) Market
9.5.5.1.1 Brazil Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.5.5.1.2 Brazil Stem Cell Umbilical Cord Blood (UCB) Market by Disease
9.5.5.2 Argentina Stem Cell Umbilical Cord Blood (UCB) Market
9.5.5.2.1 Argentina Stem Cell Umbilical Cord Blood (UCB) Market by Storage Option
9.5.5.2.2 Argentina Stem Cell Umbilical Cord Blood (UCB) Market by Disease
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. STEM CELL UMBILICAL CORD BLOOD (UCB) MARKET, KEY COMPANY PROFILES
11.1. CBR SYSTEMS, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. CORDLIFE SCIENCES INDIA PVT. LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CRYO-CELL INTERNATIONAL, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CRYOSAVE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CRYOVIVA INDIA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLOBAL CORD BLOOD CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. LIFECELL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. REGROW BIOSCIENCES PVT. LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SMART CELLS INTERNATIONAL LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VIACORD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
  1.  CBR Systems, Inc.
  2.  Cordlife Sciences India Pvt. Ltd.
  3.  Cryo-Cell International, Inc.
  4.  CryoSave
  5.  Cryoviva India
  6.  Global Cord Blood Corporation
  7.  Lifecell
  8.  Regrow Biosciences Pvt. Ltd.
  9.  Smart Cells International Ltd.
  10.  ViaCord